Frontera Therapeutics is a biotechnology company that produces and delivers gene therapy solutions. It develops APEX Technology and Manufacturing Platform, an adeno-associated virus (AAV) gene expression system that optimizes both new and clinically validated AAV vectors. The company focuses not only on orphan diseases but also on larger patient markets including ophthalmology, hematology, neurology, and metabolic diseases.